Join Exoma CommunityJoin

GHK-Cu (Copper Tripeptide): scientific evidence from Pickart 1973 to today

Comprehensive review of the copper tripeptide GHK-Cu (Gly-His-Lys + Cu²⁺): discovery by Pickart in 1973, molecular mechanism, in vitro and preclinical evidence, comparison vs basic GHK and BPC-157, and presentations available in Mexico.

GHK-Cu (Copper Tripeptide): scientific evidence from Pickart 1973 to today

· Publicado el · Actualizado el

Comprehensive review of the copper tripeptide GHK-Cu (Gly-His-Lys + Cu²⁺): discovery by Pickart in 1973, molecular mechanism, in vitro and preclinical evidence, comparison vs Basic GHK y BPC-157, and presentations available in Mexico.

TL;DR

GHK-Cu is a natural tripeptide Glycyl-L-Histidyl-L-Lysine (Gly-His-Lys) complexed with divalent copper (Cu²⁺) in a 1:1 ratio. Isolated by Loren Pickart in 1973 from human serum albumin, it has accumulated >50 years of literature on extracellular matrix modulation, gene expression and metalloenzymes. EXOMA Peptides offers 50 mg and 100 mg presentations with HPLC purity and COA per batch, exclusively for research use.

Index

  1. Historia y descubrimiento
  2. Estructura química y complejación con cobre
  3. Mecanismos moleculares
  4. Evidencia in vitro y preclínica
  5. GHK-Cu vs GHK básico vs BPC-157
  6. Stability, reconstitution, and storage
  7. Presentaciones disponibles in Mexico
  8. Marco regulatorio y advertencia
  9. FAQ
  10. References

1. History and discovery

Loren Pickart isolated the GHK tripeptide in 1973 while investigating a serum factor capable of reversing aging-associated changes in cultures of old rat hepatocytes. The first publication described its ability to restore protein synthesis to the pattern observed in young rat hepatocytes:

Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. doi:10.1038/newbio243085a0

In 1980, Pickart and Lovejoy demonstrated that the tripeptide's activity depends critically on its complexation with divalent copper (Cu²⁺), which gave rise to the GHK-Cu complex used in virtually all subsequent literature.

2. Chemical structure and copper complexation

GHK-Cu is a coordination complex in which the Cu²⁺ ion binds to:

Molecular formula of the free peptide: C₁₄H₂₄N₆O₄ (MW 340.4 g/mol). The complex with copper adds Cu²⁺ and usually includes acetate counterions from the synthesis process.

The characteristic blue-turquoise color of the reconstituted solution is a visual proxy for the integrity of the copper-tripeptide complex. Degradation by light, oxidation or extreme pH discolors the solution.

3. Molecular mechanisms

The literature on GHK-Cu reports multiple mechanistic axes —all in in vitro systems or preclinical models:

4. In vitro and preclinical evidence

Dermal fibroblasts

Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343-346.

Transcriptomic analysis

Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Res Int. 2015;2015:648108. doi:10.1155/2015/648108

Models of tissue damage in rodents

Multiple studies have documented modulation of healing in preclinical rodent models, in topical and infiltrated application.

Hair and hair follicle models

Pyo HK et al. The Effect of Tripeptide-Copper Complex on Human Hair Growth in Vitro. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833

Toxicology

No significant adverse events have been reported in published preclinical models with doses within the physiological range. Copper toxicity remains within safe margins owing to the binding of Cu²⁺ to the tripeptide.

5. GHK-Cu vs basic GHK vs BPC-157

AtributoGHK-CuBasic GHKBPC-157
StructureTripeptide + Cu²⁺Tripeptide librePentadecapéptido
OriginAlbúmina sérica humanaTripeptide aisladoDerivado proteína gástrica
Mecanismo dominanteMetalo-enzimas + MECVariable (sin cobre)NO/VEGF
Color en soluciónAzul-turquesaIncoloroIncoloro
Literatura>50 años, >250 papersLimitada~25 años, ~50 papers

GHK-Cu and BPC-157 are structurally unrelated molecules and their research lines point to different biological contexts.

6. Stability, reconstitution and storage

Standard procedure (research use):

  1. Disinfect the stopper of the lyophilized vial and of the vial of bacteriostatic water
  2. Aspirar el volumen calculado de BAC con jeringa de insulina
  3. Inject slowly onto the inner wall
  4. Rotar suavemente hasta solución turquoise-blue transparente
  5. Almacenar refrigerado (2–8 °C) strictly protected from light

Photodegradation is the main mode of degradation. Avoid violent agitation and freeze-thaw cycles.

7. Presentations available in Mexico

EXOMA Peptides offers 2 presentations of lyophilized GHK-Cu with HPLC purity and COA per batch:

Envío 1-4 días hábiles según zona a toda la República. $200 MXN fijo; gratuito desde $2,000 MXN. GHK-Cu scientific hub with a price table and availability by lot.

8. Regulatory framework and warning

EXOMA Peptides markets GHK-Cu exclusively for research use in vitro or in preclinical models.

9. Frequently asked questions

Consult the validated FAQs on each GHK-Cu presentation in the hub page.

10. Selected references

  1. Pickart L, Thaler MM. Nat New Biol. 1973;243:85-87. doi:10.1038/newbio243085a0
  2. Pickart L, Lovejoy S. Methods Enzymol. 1987;147:314-328.
  3. Maquart FX et al. FEBS Lett. 1988;238:343-346. doi:10.1016/0014-5793(88)80346-8
  4. Pickart L. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435
  5. Pickart L, Vasquez-Soltero JM, Margolina A. BioMed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
  6. Pyo HK et al. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833
  7. Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
  8. Hostynek JJ et al. Inflamm Res. 2010;59(11):983-988. doi:10.1007/s00011-010-0214-4
  9. Gruchlik A et al. Acta Pol Pharm. 2012;69(6):1303-1306.
  10. Pickart L, Margolina A. J Aging Res Clin Pract. 2012;1(2):92-100.

Material for research use only. It does not constitute a clinical recommendation.


References

Material for research use only. The following primary sources support the scientific claims of this article:

  1. Huang PJ, Huang YC, Su MF, et al. In vitro observations on the influence of copper peptide aids for the LED photoirradiation of fibroblast collagen synthesis. Photomed Laser Surg. 2007;25(3):183-190. (in vitro)
  2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987.

Products available at EXOMA

See also

Literature on the compounds cited

  • Sobre Basic GHK: GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (Pickart, et al. · BioMed Research International · 2015) PMID 26236730.
  • Sobre Basic GHK: The human tri-peptide GHK and tissue remodeling (Pickart, et al. · Journal of Biomaterials Science, Polymer Edition · 2008) PMID 18644225.
  • Sobre Basic GHK: The potential of GHK as an anti-aging peptide (Pickart, et al. · Aging Pathobiology and Therapeutics · 2020) PMID 35083444.
  • About BPC-157: Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats (Xue, et al. · World Journal of Gastroenterology · 2004) PMID 15052688.
  • About BPC-157: Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157 (Sikiric, et al. · Current Medicinal Chemistry · 2012) PMID 22300085.
  • About BPC-157: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration (Chang, et al. · Journal of Applied Physiology · 2011) PMID 21030672.